Identification of in vivo CFTR conformations during biogenesis and upon misfolding by covalent protein painting (CPP)
Sandra PankowiD, Casimir BambergeriD, Salvador Martínez‐BartoloméiD, Sung Kyu ParkiD, John R. YatesiD
Abstract
In vivo characterization of protein structures or protein structural changes after perturbation is a major challenge. Therefore, experiments to characterize protein structures are typically performed in vitro and with highly purified proteins or protein complexes. Using a novel low-resolution method named Covalent Protein Painting (CPP) that allows the characterization of protein conformations in vivo, we are the first to report how an ion channel, the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), is conformationally changed during biogenesis and channel opening in the cell. Our study led to the identification of a novel opening mechanism for CFTR by revealing that the interaction of the intracellular loop 2 (ICL2) with the nucleotide binding domain 2 (NDB2) of CFTR is needed for channel gating, and this interaction occurs concomitantly with changes to the narrow part of the pore and the walker A lysine in NBD1. However, the ICL2:NBD2 interface, which forms a "ball-in-a-socket" motif, is uncoupled during biogenesis, likely to prevent inadvertent channel activation during transport. In particular, solvent accessibility of lysine 273 (K273) in ICL2 changes with the opening and closing of the channel. Mutation of K273 severely impaired CFTR biogenesis and led to accumulation of CFTR in the Golgi and TGN. CPP further revealed that, even upon treatment with current approved drugs or at permissive temperature, the uncoupled state of ICL2 is a prominent feature of the misfolded CFTR mutants {Delta}F508 and N1303K that cause Cystic Fibrosis (CF), which suggests that stabilization of this interface could produce a more efficient CF drug. CPP is able to characterize a protein in its native environment and measure the effect of complex PTMs and protein interactions on protein structure, making it broadly applicable and invaluable for the development of new therapies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Correcting mutant CFTR with a stabilizing nanobody reveals a novel active conformation of the channel
Marie Overtus, James N. Charlick, … Cédric Govaerts·bioRxiv·Oct 8, 2025
- Cryo-EM visualization of an active high open probability CFTR ion channel
J. F. Fay, L. A. Aleksandrov, … J. Z. Chen·bioRxiv·Mar 2, 2018
- A Topological Switch Enables Misfolding of the Cystic Fibrosis Transmembrane Conductance Regulator
Daniel Scholl, Maud Sigoillot, … Cédric Govaerts·bioRxiv·Jul 9, 2020
- Influence of Disease-Causing Mutations and Ivacaftor on the Dynamics of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein
Diana‐Florentina Veselu, Deborah K. Shoemark, Marc W. van der Kamp·Journal of Computational Biophysics and ChemistryPeer-reviewed·Dec 20, 2025
- Structural basis for CFTR inhibition by CFTRinh-172
P. Young, J. Levring, … J. Chen·bioRxiv·Oct 11, 2023
- Protein interactions, calcium, phosphorylation, and cholesterol modulate CFTR cluster formation on membranes
Yimei Wan, Rhea Hudson, … Jonathon A. Ditlev·Proceedings of the National Academy of SciencesPeer-reviewed·Mar 10, 2025